Literature DB >> 15465328

Synthesis and antibacterial activity of novel and potent DNA gyrase inhibitors with azole ring.

Akihiko Tanitame1, Yoshihiro Oyamada, Keiko Ofuji, Mika Fujimoto, Kenji Suzuki, Tomohiko Ueda, Hideo Terauchi, Motoji Kawasaki, Kazuo Nagai, Masaaki Wachi, Jun-ichi Yamagishi.   

Abstract

The 4-piperidyl moiety and the pyrazole ring in 1-(3-chlorophenyl)-5-(4-phenoxyphenyl)-3-(4-piperidyl)pyrazole 2, which has previously shown improved DNA gyrase inhibition and target-related antibacterial activity, were transformed to other groups and the in vitro antibacterial activity of the synthesized compounds was evaluated. The selected pyrazole, oxazole and imidazole derivatives showed moderate inhibition against DNA gyrase and topoisomerase IV with similar IC(50) values (IC(50)=9.4-25 microg/mL). In addition, many of the pyrazole, oxazole and imidazole derivatives synthesized in this study exhibited potent antibacterial activity against quinolone-resistant clinical isolates and coumarin-resistant laboratory isolates of Gram-positive bacteria with minimal inhibitory concentration values equivalent to those against susceptible strains.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15465328     DOI: 10.1016/j.bmc.2004.08.010

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  13 in total

Review 1.  In front of and behind the replication fork: bacterial type IIA topoisomerases.

Authors:  Claudia Sissi; Manlio Palumbo
Journal:  Cell Mol Life Sci       Date:  2010-02-18       Impact factor: 9.261

2.  Synthesis and Antimicrobial Activity of N,N'-Bis(2-hydroxylbenzyl)-1,2-ethanediamine Derivatives.

Authors:  Musiliyu A Musa; M Omar F Khan; Arden Aspedon; John S Cooperwood
Journal:  Lett Drug Des Discov       Date:  2010-03       Impact factor: 1.150

3.  Biological and docking studies of topoisomerase IV inhibition by thiosemicarbazides.

Authors:  Agata Siwek; Paweł Stączek; Monika Wujec; Joanna Stefańska; Urszula Kosikowska; Anna Malm; Stefan Jankowski; Piotr Paneth
Journal:  J Mol Model       Date:  2010-11-16       Impact factor: 1.810

4.  Hydrazine-mediated cyclization of Ugi products to synthesize novel 3-hydroxypyrazoles.

Authors:  Arthur Y Shaw; Jonathan A McLaren; Gary S Nichol; Christopher Hulme
Journal:  Tetrahedron Lett       Date:  2012-03-24       Impact factor: 2.415

Review 5.  Natural product inhibitors of Hsp90: potential leads for drug discovery.

Authors:  M W Amolins; B S J Blagg
Journal:  Mini Rev Med Chem       Date:  2009-02       Impact factor: 3.862

6.  Novel [l,2,4]triazolo[3,4-a]isoquinoline chalcones as new chemotherapeutic agents: Block IAP tyrosine kinase domain and induce both intrinsic and extrinsic pathways of apoptosis.

Authors:  Magda F Mohamed; Farid M Sroor; Nada S Ibrahim; Ghada S Salem; Hadeer H El-Sayed; Marwa M Mahmoud; Menna-Allah M Wagdy; Amina M Ahmed; Aya-Allah T Mahmoud; Somia S Ibrahim; Mariam M Ismail; Sanaa Mohy Eldin; Fatma M Saleh; Hamdi M Hassaneen; Ismail A Abdelhamid
Journal:  Invest New Drugs       Date:  2020-08-28       Impact factor: 3.850

7.  5-(2-Hy-droxy-phen-yl)-3-methyl-4,5-di-hydro-1H-pyrazole-1-carbaldehyde.

Authors:  Ping Cui; Xin-Long Li
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-08-18

8.  Synthesis of new pyrazolyl-2, 4-thiazolidinediones as antibacterial and antifungal agents.

Authors:  Deepak K Aneja; Poonam Lohan; Sanjiv Arora; Chetan Sharma; Kamal R Aneja; Om Prakash
Journal:  Org Med Chem Lett       Date:  2011-11-08

9.  Crystal structure of 6-amino-4-(3-bromo-4-meth-oxy-phen-yl)-3-methyl-2,4-di-hydro-pyrano[2,3-c]pyrazole-5-carbo-nitrile dimethyl sulfoxide monosolvate.

Authors:  Sammer Yousuf; Huma Bano; Munira Taj Muhammad; Khalid Mohammed Khan
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2015-06-06

10.  Synthesis, structure and antibacterial activity of potent DNA gyrase inhibitors: N'-benzoyl-3-(4-bromophenyl)-1H-pyrazole-5-carbohydrazide derivatives.

Authors:  Juan Sun; Peng-Cheng Lv; Yong Yin; Rong-Ju Yuan; Jian Ma; Hai-Liang Zhu
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.